Search

everythinglearnresearchcommunity

for

Search:↓

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Adding a second method to PROTACs could improve cancer treatment.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Medications for PCOS don't seem to raise heart disease risk.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Hormones control reproduction and are crucial for body balance.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.